Free Trial

Oramed Pharmaceuticals (ORMP) Earnings Date, Estimates & Call Transcripts

Oramed Pharmaceuticals logo
$2.11 -0.04 (-1.86%)
Closing price 04:00 PM Eastern
Extended Trading
$2.14 +0.04 (+1.66%)
As of 05:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Oramed Pharmaceuticals Earnings Summary

Oramed Pharmaceuticals released Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.19, which missed the consensus estimate of -$0.03 by $0.16. Quarterly revenue was reported to be $2 million. With a trailing EPS of -$0.44 and a P/E Ratio of 19.18, Oramed Pharmaceuticals' earnings are expected to decrease next year, from ($0.03) to ($0.19) per share.

Q1 2025 Earnings Resources

Latest Q1 2025
Earnings Date
May. 15Estimated
Consensus EPS
(May. 15)
-$0.03
Actual EPS
(May. 15)
-$0.19 Missed By -$0.16
Actual Revenue
(May. 15)
$2.00M
Get Oramed Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oramed Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ORMP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ORMP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Oramed Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.05-$0.01-$0.03
Q2 20252-$0.06-$0.01-$0.04
Q3 20252-$0.07-$0.01-$0.04
Q4 20252-$0.08-$0.03-$0.06

Oramed Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025-$0.03-$0.19 -$0.16-$0.19-$2.00M
3/27/2025Q4 2024-$0.03$0.01+$0.04$0.01--
8/14/2024Q2 2024$0.01$0.22+$0.21$0.22--
5/9/2024Q1 2024$0.02$0.04+$0.02$0.04--
3/6/2024Q4 2023-$0.12-$0.08+$0.04-$0.49--
11/9/2023Q3 2023-$0.09-$0.08+$0.01-$0.08--
8/10/2023Q2 2023-$0.11-$0.03+$0.08-$0.03$0.70M$0.67M

Oramed Pharmaceuticals Earnings - Frequently Asked Questions

Oramed Pharmaceuticals (NASDAQ:ORMP) last announced its quarterly earning data on Thursday, May 15, 2025. Learn more on ORMP's earnings history.

In the previous quarter, Oramed Pharmaceuticals (NASDAQ:ORMP) missed the analysts' consensus estimate of ($0.03) by $0.16 with a reported earnings per share (EPS) of ($0.19). Learn more on analysts' earnings estimate vs. ORMP's actual earnings.

Oramed Pharmaceuticals (NASDAQ:ORMP) has a recorded annual revenue of $1.34 million.

Oramed Pharmaceuticals (NASDAQ:ORMP) has a recorded net income of $5.53 million. ORMP has generated -$0.44 earnings per share over the last four quarters.

Oramed Pharmaceuticals (NASDAQ:ORMP) has a trailing price-to-earnings ratio of 19.18.

Oramed Pharmaceuticals's earnings are expected to decrease from ($0.03) per share to ($0.19) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ORMP) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners